SEC Form 5 · accession 0001125345-17-000004
MACROGENICS INC · MGNX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Koenig
Officer — President and CEO · Director
Period of report
Dec 31, 2016
Accepted (ET)
Jan 19, 2017 · 4:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001125345
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 17, 2016 | J | 79,898 | $0.00 | D | 53,265 | D | |
| Common StockF2 | May 18, 2016 | J | 34,619 | $0.00 | D | 53,265 | D | |
| Common StockF1 | May 17, 2016 | J | 79,898 | $0.00 | A | 167,782 | I | By Scott Koenig Family Irrevocable Trust |
| Common StockF2 | May 18, 2016 | J | 34,619 | $0.00 | A | 167,782 | I | By Scott Koenig Family Irrevocable Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1(1) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/17/16 was $18.04 per share.
- F2(2) Transaction was a transfer of direct ownership by reporting person to indirect ownership (Family Trust). Closing price on 5/18/16 was $21.06 per share.